Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Sequencing » Aviir Develops Inherited Cardiovascular Disease Tests to Run on Both PGM, MiSeq

Aviir Develops Inherited Cardiovascular Disease Tests to Run on Both PGM, MiSeq

Apr 10, 2013
|
Julia Karow
Premium

Cardiovascular diagnostics company Aviir plans to launch this spring clinical tests for more than a dozen inherited cardiovascular disorders that run on both the Ion Torrent PGM and the Illumina MiSeq.

The company, which has a CLIA-certified facility in Irvine, Calif., called Aviir Diagnostics Laboratories, was founded in 2005 by cardiologists and researchers at the Stanford University School of Medicine. It focuses on diagnostic tests for the prevention and management of cardiovascular disease and metabolic syndromes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

To Keep Up

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

On the Rise in the City

The New York Times reports that a new viral variant of concern has been identified in New York City.

Nature Studies Present Single-Cell Map of Cell Cycle, Approach Identifies Cancer Treatment Resistance Pathways, More

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

Support for Another

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Mar
31
Featured Webinar

Development and Commercialization of a Novel CRISPR-Based SARS CoV-2 Test

Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test. 

What's Popular?

In Clinical Sequencing

  1. Adaptive Biotechnologies Q4 Revenues Rise 25 Percent

  2. Adaptive Biotechnologies Touts New Era of T Cell-Based Dx With T-Detect COVID Launch

    Premium

  3. AnchorDx Closes $40M Series C Financing Round

  4. Researchers Aim to Improve Lynch Syndrome Testing With Genetic-Epigenetic Combination Method

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.